Citation Impact
Citing Papers
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection
2004
Mucosal memory CD8+ T cells are selected in the periphery by an MHC class I molecule
2011
T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?
2014
Immune control of HIV-1 after early treatment of acute infection
2000 Nature
Development of αβ T cells in the human thymus
2002
Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts
2005
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
2007
Transmission of HIV-1 drug resistance
2004
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Concomitant regulation of T-cell activation and homeostasis
2004
Barriers to HAART Adherence Among Human Immunodeficiency Virus–Infected Adolescents
2003
Current status of gene therapy strategies to treat HIV/AIDS
2005
T cell exhaustion
2011 Standout
HIV preferentially infects HIV-specific CD4+ T cells
2002 Nature
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda
2003
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
2013 Nature
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
2011
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
2011
A Prospective, Randomized Trial of Structured Treatment Interruption for Patients with Chronic HIV Type 1 Infection
2005
Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection
2003
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Structured Treatment Interruptions for the Management of HIV Infection
2001
HIV disease: fallout from a mucosal catastrophe?
2006
The interaction of HIV with dendritic cells: outcomes and pathways
2007 StandoutNobel
The role of secondary lymphatic tissue in immune deficiency of HIV infection
2008
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART
2005
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Antiretroviral Treatment for Adult HIV Infection in 2002
2002
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
De novo T-cell generation in patients at different ages and stages of HIV-1 disease
2004
Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study
2007
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
Discontinuation of Antiretroviral Therapy Commenced Early during the Course of Human Immunodeficiency Virus Type 1 Infection, with or without Adjunctive Vaccination
2002
Therapeutic dendritic-cell vaccine for simian AIDS
2002
Molecular and cellular insights into T cell exhaustion
2015 Standout
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
2003 Standout
Equivalent Immunogenicity of the Highly Attenuated Poxvirus-Based ALVAC-SIV and NYVAC-SIV Vaccine Candidates in SIVmac251-Infected Macaques
2002
The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats
2003
Evaluation of antiretrovirals in animal models of HIV infection
2009
HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation
2004
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
2010
The multifactorial nature of HIV-1 latency
2004
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Adherence to Medication
2005 Standout
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4 + and CD8 + T cell turnover in HIV-infected patients
2000
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
2008
Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads
2003
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines
2007
Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
2006
Defective Human Immunodeficiency Virus-Specific CD8 + T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
2009
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
IL-2–induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation
2004
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection
2003
The Challenge of Viral Reservoirs in HIV-1 Infection
2002
Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies
2007 StandoutNobel
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus
2005
Subpopulations of Equine Infectious Anemia Virus Rev Coexist In Vivo and Differ in Phenotype
2003
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily
2004
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
T Cell Dynamics in HIV-1 Infection
2003
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution
2012
Interventions for enhancing medication adherence
2014 Standout
Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 Nef-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption
2005
Immunologic Control of HIV-1
2002
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy
2005
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
2007
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages
2003 StandoutNobel
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells
2014
Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection
2002
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4 + T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
2001
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
2001
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Sparse production but preferential incorporation of recently produced naïve T cells in the human peripheral pool
2008
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome
2010
Disrupting T-cell homeostasis: how HIV-1 infection causes disease.
2004
Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF
2004 StandoutNobel
In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
2005
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
2004 StandoutNobel
The Simian Immunodeficiency Virus ΔnefVaccine, after Application to the Tonsils of Rhesus Macaques, Replicates Primarily within CD4+T Cells and Elicits a Local Perforin-Positive CD8+T-Cell Response
2002 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes
2011
CXCR3 Is Induced Early on the Pathway of CD4+ T Cell Differentiation and Bridges Central and Peripheral Functions
2003
Works of Christian Yoder being referenced
Long‐Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic Parameters
2003
Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
2000
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient
1999
Incomplete CD4 T Cell Recovery in HIV-1 Infection After 12 Months of Highly Active Antiretroviral Therapy Is Associated With Ongoing Increased CD4 T Cell Activation and Turnover
2003
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression
2000
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy
2001
Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy
2000
Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8+T Cells
2008
Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy
2003
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
2001
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
1999
Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection
2001
Naive T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naive T-Cell Depletion
2006